These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6553514)

  • 1. Potentiation of the defective monocyte chemotaxis in Hodgkin's disease by in vitro tuftsin treatment.
    Lukács K; Berényi E; Kávai M; Szegedi G; Szekerke M
    Cancer Immunol Immunother; 1983; 15(2):162-3. PubMed ID: 6553514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased tuftsin concentrations in patients who have undergone splenectomy.
    Spirer Z; Zakuth V; Diamant S; Mondorf W; Stefanescu T; Stabinsky Y; Fridkin M
    Br Med J; 1977 Dec; 2(6102):1574-6. PubMed ID: 579324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulating effect of tuftsin and its analogues on the defective monocyte chemotaxis in systemic lupus erythematosus.
    Lukács K; Szabó G; Sonkoly I; Végh E; Gács J; Szekerke M; Szegedi G
    Immunopharmacology; 1984 Jun; 7(3-4):171-8. PubMed ID: 6469603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does tuftsin alter phagocytosis by human polymorphonuclear neutrophils?
    Cooper MR; DeChatelet LR; Shirley PS; Cooper MR
    Inflammation; 1982 Mar; 6(1):103-12. PubMed ID: 6896319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tuftsin on migration of polymorphonuclear and mononuclear human leukocytes in leukocyte migration agarose test.
    Horsmanheimo A; Horsmanheimo M; Fudenberg HH
    Clin Immunol Immunopathol; 1978 Nov; 11(3):251-5. PubMed ID: 581363
    [No Abstract]   [Full Text] [Related]  

  • 6. Monocyte chemotaxis and effect of levamisole in Hodgkin's disease.
    Lukács K; Frendl G; Berényi E; Kávai M; Szabó G; Szegedi G
    Acta Med Acad Sci Hung; 1980; 37(2):145-50. PubMed ID: 7457021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration enhancement by tuftsin of human mononuclear cells and its effect on the migration inhibition factor test with tumor antigens.
    Nishioka K
    Gan; 1978 Aug; 69(4):569-72. PubMed ID: 581379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming of normal human neutrophils by tachykinins: tuftsin-like inhibition of in vitro chemotaxis stimulated by formylpeptide or interleukin-8.
    Wiedermann CJ; Niedermühlbichler M; Zilian U; Geissler D; Lindley I; Braunsteiner H
    Regul Pept; 1991 Nov; 36(3):359-68. PubMed ID: 1811272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective phagocytosis due to deficiencies involving the tetrapeptide tuftsin.
    Najjar VA
    J Pediatr; 1975 Dec; 87(6 Pt 2):1121-4. PubMed ID: 1242395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay of the phagocytosis-stimulating peptide tuftsin in normal and splenectomized subjects.
    Spirer Z; Zakuth V; Bogair N; Fridkin M
    Eur J Immunol; 1977 Feb; 7(2):69-74. PubMed ID: 577481
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes.
    Fridkin M; Stabinsky Y; Zakuth V; Spirer Z
    Biochim Biophys Acta; 1977 Jan; 496(1):203-11. PubMed ID: 576412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of [L-3,4-dehydroproline3]-tuftsin.
    Amoscato AA; Babcock GF; Nishioka K
    Peptides; 1984; 5(3):489-94. PubMed ID: 6548023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased monocyte function in patients with Hodgkin's disease.
    Leb L; Merritt JA
    Cancer; 1978 May; 41(5):1794-803. PubMed ID: 647628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of familial and acquired phagocytosis deficiency involving the tetrapeptide, thr-lys-pro-arg, tuftsin.
    Najjar VA
    Exp Cell Biol; 1978; 46(1-2):114-26. PubMed ID: 579629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.
    Tzehoval E; Segal S; Stabinsky Y; Fridkin M; Spirer Z; Feldman M
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3400-4. PubMed ID: 277940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in immune status in patients undergoing splenectomy for the staging of Hodgkin's disease.
    Hancock BW; Bruce L; Ward AM; Richmond J
    Br Med J; 1976 Feb; 1(6005):313-5. PubMed ID: 1247837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of action of the phagocytosis-stimulating peptide tuftsin.
    Stabinsky Y; Bar-Shavit Z; Fridkin M; Goldman R
    Mol Cell Biochem; 1980 Apr; 30(2):71-7. PubMed ID: 6247642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central effects of the tetrapeptide tuftsin].
    Val'dman AV; Kozlovskaia MM; Ashmarin IP; Mineeva MF; Anokhin KV
    Biull Eksp Biol Med; 1981 Jul; 92(7):31-3. PubMed ID: 6117337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuftsin and D-Arg3-tuftsin possess analgesic action.
    Herman ZS; Stachura Z; Opiełka L; Siemion IZ; Nawrocka E
    Experientia; 1981 Jan; 37(1):76-7. PubMed ID: 6894124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activity of tuftsin.
    Martinez J; Winternitz F
    Mol Cell Biochem; 1981 Dec; 41():123-36. PubMed ID: 6799777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.